Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Week in Review: TAVR fears | The top children's heart hospitals | Family sues after doctor's death | Obesity drugs under review

News You Need to Know Today
Week in Review: TAVR fears | The top children's heart hospitals | Family sues after doctor's death | Obesity drugs under review
Saturday, October 11, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

This Week’s News

Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients

Are too many low-risk patients with severe AS undergoing TAVR instead of SAVR? According to one group of clinicians, "a significant public health concern may be looming."

READ MORE >
cardiologist viewing heart data
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists, heart surgeons sound alarm over widespread use of TAVR in low-risk patients

Share on Twitter Share on Facebook Share on Linkedin
cardiologist viewing heart data
Are too many low-risk patients with severe AS undergoing TAVR instead of SAVR? According to one group of clinicians, "a significant public health concern may be looming."
READ MORE >

The top 25 children's heart hospitals in the US

Patient outcomes, safety data and physician feedback were all used to rank the top children's hospitals for pediatric cardiology and heart surgery in the United States. Did your facility make the cut? 

READ MORE >
The Society for Cardiovascular Angiography and Interventions (SCAI) has responded to the U.S. Food and Drug Administration’s (FDA’s) recommendation that all infants and young children who receive iodinated contrast media (ICM) undergo thyroid testing. The group pushed back against this proposal, emphasizing that implementation would have “far-reaching consequences.”
Share on Twitter Share on Facebook Share on Linkedin

The top 25 children's heart hospitals in the US

Share on Twitter Share on Facebook Share on Linkedin
The Society for Cardiovascular Angiography and Interventions (SCAI) has responded to the U.S. Food and Drug Administration’s (FDA’s) recommendation that all infants and young children who receive iodinated contrast media (ICM) undergo thyroid testing. The group pushed back against this proposal, emphasizing that implementation would have “far-reaching consequences.”
Patient outcomes, safety data and physician feedback were all used to rank the top children's hospitals for pediatric cardiology and heart surgery in the United States. Did your facility make the cut? 
READ MORE >

Cardiologist dies after choking on flight—family’s lawsuit points to alleged negligence

According to the lawsuit, the doctor followed a strict vegetarian diet and choked after he was served meat. The family also claims the airline delayed care by waiting too long to perform an emergency landing.

READ MORE >
healthcare AI and aviation
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist dies after choking on flight—family’s lawsuit points to alleged negligence

Share on Twitter Share on Facebook Share on Linkedin
healthcare AI and aviation
According to the lawsuit, the doctor followed a strict vegetarian diet and choked after he was served meat. The family also claims the airline delayed care by waiting too long to perform an emergency landing.
READ MORE >

Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health

The popularity of various obesity management medications has increased significantly in recent years. According to a new analysis of more than 60,000 patients, some of these drugs are associated with more cardiovascular benefits than others.

READ MORE >
obesity semaglutide tirzepatide GLP-1 drugs weight loss
Share on Twitter Share on Facebook Share on Linkedin

Obesity drugs under review: Semaglutide, tirzepatide, naltrexone/bupropion all boost heart health

Share on Twitter Share on Facebook Share on Linkedin
obesity semaglutide tirzepatide GLP-1 drugs weight loss
The popularity of various obesity management medications has increased significantly in recent years. According to a new analysis of more than 60,000 patients, some of these drugs are associated with more cardiovascular benefits than others.
READ MORE >

Trump's $100K visa fee will be bad for heart patients

"There is already a deficit of doctors in the U.S., and this will make it worse," one cardiologist told Cardiovascular Business. Medical societies throughout the country seem to agree. 

READ MORE >
President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.
Share on Twitter Share on Facebook Share on Linkedin

Trump's $100K visa fee will be bad for heart patients

Share on Twitter Share on Facebook Share on Linkedin
President Trump's presidential proclamation Sept. 19 to implement a $100,000 fee for H-1B visa applications had immediate backlash from dozens of medical societies. Groups like the American Medical Association (AMA) and the American College of Cardiology (ACC) said this will cut off the flow of foreign physicians into the U.S. at a time when we cannot graduate enough American physicians to fill positions in a healthcare system that is facing a rapidly growing physician shortage.
"There is already a deficit of doctors in the U.S., and this will make it worse," one cardiologist told Cardiovascular Business. Medical societies throughout the country seem to agree. 
READ MORE >

Ultrasound renal denervation: A high-value treatment option for patients with uncontrolled hypertension

Sponsored by Recor Medical

Nearly 120 million adults in the United States have hypertension, and just 1 in 4 of them have it under control. Treatments remain limited outside of lifestyle changes and hypertensive medications that are not always effective.  

READ MORE >
recor_paradise_system_-_sonication_dark_bg.png
Share on Twitter Share on Facebook Share on Linkedin

Ultrasound renal denervation: A high-value treatment option for patients with uncontrolled hypertension

Sponsored by Recor Medical

Share on Twitter Share on Facebook Share on Linkedin
recor_paradise_system_-_sonication_dark_bg.png
Nearly 120 million adults in the United States have hypertension, and just 1 in 4 of them have it under control. Treatments remain limited outside of lifestyle changes and hypertensive medications that are not always effective.  
READ MORE >

ACC urges Congress to restore telemedicine flexibilities

The American College of Cardiology, like many other U.S. medical societies, is fighting to bring back telehealth policies that expired at the end of September.

READ MORE >
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option.
Share on Twitter Share on Facebook Share on Linkedin

ACC urges Congress to restore telemedicine flexibilities

Share on Twitter Share on Facebook Share on Linkedin
Telecardiology saw a major boost during the COVID-19 pandemic. Many health systems now want to keep it as a permanent treatment option.
The American College of Cardiology, like many other U.S. medical societies, is fighting to bring back telehealth policies that expired at the end of September.
READ MORE >

From heart pumps to politics: Former medtech CEO launches campaign to be the governor of Massachusetts

Michael Minogue spent nearly two decades as the chairman, president and CEO of Abiomed, and now he is running to be the next governor of Massachusetts. 

READ MORE >
Michael Minogue (center) and other Abiomed representatives. Image courtesy of Minogue's campaign.
Share on Twitter Share on Facebook Share on Linkedin

From heart pumps to politics: Former medtech CEO launches campaign to be the governor of Massachusetts

Share on Twitter Share on Facebook Share on Linkedin
Michael Minogue (center) and other Abiomed representatives. Image courtesy of Minogue's campaign.
Michael Minogue spent nearly two decades as the chairman, president and CEO of Abiomed, and now he is running to be the next governor of Massachusetts. 
READ MORE >

Impella heart pump provides value during high-risk PCI, meta-analysis confirms

Using an Impella heart pump during high-risk PCI was linked to a reduced short-term mortality rate and an acceptable safety profile.

READ MORE >
Impella CP Johnson & Johnson MedTech Abiomed
Share on Twitter Share on Facebook Share on Linkedin

Impella heart pump provides value during high-risk PCI, meta-analysis confirms

Share on Twitter Share on Facebook Share on Linkedin
Impella CP Johnson & Johnson MedTech Abiomed
Using an Impella heart pump during high-risk PCI was linked to a reduced short-term mortality rate and an acceptable safety profile.
READ MORE >

How to take your CCTA program to the next level

Changing society guidelines and insurance policies have resulted in more interest in CCTA. To help your CCTA program expand, one expert told Cardiovascular Business, it is important to remember the close relationship between cardiology and radiology. 

READ MORE >
Jaime Warren, EdD, MBA, BHS, CNMT, NCT, FACC, vice president, care transformation, MedAxiom, an ACC company, explains some of the things centers should be thinking about when creating or expanding cardiac CT angiography (CCTA) programs.
Share on Twitter Share on Facebook Share on Linkedin

How to take your CCTA program to the next level

Share on Twitter Share on Facebook Share on Linkedin
Jaime Warren, EdD, MBA, BHS, CNMT, NCT, FACC, vice president, care transformation, MedAxiom, an ACC company, explains some of the things centers should be thinking about when creating or expanding cardiac CT angiography (CCTA) programs.
Changing society guidelines and insurance policies have resulted in more interest in CCTA. To help your CCTA program expand, one expert told Cardiovascular Business, it is important to remember the close relationship between cardiology and radiology. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib
News Alert: FDA shares new warning about Impella heart pumps after death
AHA takes on cardiac amyloidosis | Have clinicians been wrong about PAD? | FDA OKs new AI for heart failure

Pagination

    • First page « First
    • Previous page ‹‹
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup